The amendments in the bill are consistent with the policy intent of section 23, which is for New Zealanders to have timely access to safe and effective medicines where there is a public health need. The Medicines Act is an outdated piece of legislation that has not kept pace with international regulatory practice. Responding to the COVID-19 pandemic has highlighted an urgent need for amendments to the Medicines Act.